6505--Acyclovir Capsules (VA-25-00048078)
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36E79725R0033
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is seeking to procure Acyclovir Capsules through solicitation 36E79725R0033, which falls under the Pharmaceutical Preparation Manufacturing NAICS category. The solicitation was originally posted on April 29, 2025, with an initial due date of May 14, 2025, but has been amended to extend the submission deadline to May 20, 2025, at 2:30 PM CDT. The procurement is classified under Product Service Code 6505 for Drugs and Biologicals, indicating a specific pharmaceutical product requirement. While specific evaluation criteria are not detailed in the provided documentation, standard federal procurement practices typically involve assessments of technical capability, pricing, compliance with specifications, and vendor qualifications. Potential offerors must carefully review the solicitation documents and acknowledge the amendment to avoid potential rejection of their proposal.
The solicitation does not indicate any specific set-aside designations, meaning the opportunity is open to all qualified vendors. No incumbent contractor information is provided in the available documentation. The precise award value and quantity of Acyclovir Capsules are not explicitly stated in the current documents. As this is a contract opportunity from the Department of Veterans Affairs National Acquisition Center, the place of performance is likely to be within the VA healthcare system, potentially serving multiple VA medical facilities nationwide. The amendment to the solicitation suggests a structured and formal procurement process, with precise requirements for submission and potential strict compliance expectations for the pharmaceutical product being sought.
Notice text
2 versions
Update #2 · Latest ·
This amendment extends the due date and time for receipt of offers. See document for details.
Update #1 ·
N/A
Files
| File | Type | Posted |
|---|---|---|
| 36E79725R0033 0001.docx | DOCX document | |
| 36E79725R0033.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Acyclovir Capsules | Award Notice | |
| This notice | Solicitation | |
| 6505--Acyclovir Capsules (VA-25-00048078) | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity